Discover the transformative updates to UK clinical trial regulations, effective from April 2026, and learn how they aim to ...

Neuroscientists from Monash University, the University of Melbourne and University College London are calling for clinical ...

Researchers have found in a new study that high-frequency oscillatory ventilation (HFOV) may reduce the incidence of ...

Leading neuroscientists from Monash University, the University of Melbourne and University College London are calling for clinical studies to ...

In 2026, one of the hottest debates in motherhood revolves around sleep training and whether it's acceptable for a mother to ...

Around 1,300 pets are testing a new longevity drug that may help dogs live longer. Here's how it works and what it means for ...

We look at the political and government responses to risks around data sovereignty and massive dependence on the three US hyperscalers, AWS, Azure and GCP in the UK and Europe ...

The Substance Access Beneficiary Engagement Incentive (BEI), which went live on April 1, 2026, allows Medicare-connected care organizations to furnish up to $500 per year in hemp-derived products to ...

Experts explore how leukapheresis is emerging as a critical chokepoint for both autologous and allogeneic cell therapies.

After nearly 100 years of development, treatments that bolster the body's immune system to fight cancer are coming of age – ...

The FDA has released a statement saying it will “carefully shepherd” studies to advance the development of chimeric antigen receptor T-cell therapies in autoimmune and rheumatic diseases.“It is quite ...

Real-world data is increasingly used to optimize trial design, reduce recruitment burden, and support regulatory decisions, but adoption remains uneven due to challenges around data quality, ...